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Abstract
Introduction: To evaluate the effect of Ambroxol on the pulmonary surfactant
(PS) in rat pneumonia induced by Pseudomonas aeruginosa (PA).
Material and methods: The pneumonic rats were obtained by injecting
ATCC27853 intratracheally. One hundred and twenty SD rats were randomized
into four groups: normal saline and Ambroxol was injected intraperitoneally
following PA challenge in the PA/NS and PA/AM group; the other two groups
were NS/AM and NS/NS. The wet/dry weight ratio (W/D), and pathological
changes were assayed. Total proteins (TP), total phospholipid (TPL), and
dipalmitoylphosphatidylcholine (DPPC) in bronchial alveolar lavage fluid (BALF)
were analysed. Some BALF was cultured for colony counts. Ultrastructural change
of the lung was observed by electron microscopy.
Results: The W/D ratio in the PA/AM group was lower than that in the PA/NS
group; both were higher than that in the NS/NS group (p < 0.05). There were
more neutrophils in the PA/NS group than in the PA/AM group (p < 0.05), and
more in the PA/AM group than in the NS/NS group (p < 0.05). The ratio of
DSPC/TPL and DSPC/TP in the BALF in PA/NS group was lower than that in the
PA/AM group; DSPC/TPL and DSPC/TP ratios also increased in the NS/AM group.
The PA colony numbers in the PA/AM group were lower than in the PA/NS group
(p > 0.05). In the PA/NS group, vacuolation occurred in the lamellar body of
alveolar type 2 cells (AT2) and the PS layer was rough and broken in some areas.
In the PA/AM group, the degree of vacuolation of the lamellar body was less
than in the PA/NS group.
Conclusions: Ambroxol could protect rats from pneumonia by improving the
level of endogenous PS, especially DPPC.
Key words: pulmonary surfactant, Pseudomonas aeruginosa, bronchoalveolar lavage,
pneumonia, Ambroxol.
Introduction
Pseudomonas aeruginosa (PA) is the one of the most common
pathogens involved in nosocomial pneumonia and is responsible for both
high mortality and morbidity in critically ill patients [1]. Presently, treatment
for this disorder consists primarily of antibiotic administration, but typical
antibiotic combinations have little effect on patient morbidity and mortality
with the rising resistance rate to many drugs [2, 3]. This is derived from
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resistant-antibiotics [4-6], especially developing
drug-induced resistance. Therefore other methods
apart from antibiotics should be investigated to
manage this disorder.
Studies on bronchoalveolar lavage fluid (BALF)
obtained from patients with both Gram-positive
and -negative pneumonia have demonstrated
alterations in the endogenous surfactant system
[7-9]. This is partially due to the degradation of
bacterial content to the surfactant, for example, the
combination of phospholipase C and lipase from
PA was reported to result in degradation of
dipalmitoylphosphatidylcholine (DPPC), producing
palmitic acid and dipalmitoylglycerol, though lipase
alone produced no degradation [10]. Further
evidence suggests that surfactant may play a role
in the lung dysfunction associated with pneumonia
stems from the observed surfactant alterations in
patients with acute respiratory distress syndrome
(ARDS), which is associated with similar alterations
in lung mechanics and the surfactant system. Some
studies have shown that these changes contribute
to the lung dysfunction observed in ARDS and
exogenous surfactant has shown promise as
a therapeutic modality in these patients and animal
models such as rabbits and rats [11-14].
But, the elements of exogenous pulmonary
surfactant are different from one another; for
example, Exosurf is a synthetic pulmonary
surfactant [15], Survanta is a natural bovine
surfactant extract (including SP-B, SP-C, not SP-A)
[15], Curosurf is a porcine surfactant extract (SP-B,
SP-C) [16]. Therefore there have been some
difficulties to contrast the efficacy between any two
medications and set up a standard formula of PS
administration. But Ambroxol, a mucolytic agent,
exhibits not only antioxidant and anti-inflammatory
properties with reduction of the release of
inflammatory cytokines from bronchoalveolar
macrophages, monocytes and granulocytes [17], but
also, it is found to increase alveolar type II cell (AT2)-
secreted surfactant proteins [18]. Therefore if used
as the actor of a surfactant, it can be administered
easily and contrasted the efficacy. There is now
ample evidence that Ambroxol is a very potent
inducer of surfactant synthesis in young and adult
organisms and in alveolar type II cells from different
animals [19]. This study was performed to use
Ambroxol for treating pneumonia induced by PA
and to provide some support for further clinical use.
Material and methods
Materials
Animals
Protocols for animal care and experimental
management were approved by the Fudan
University’s Scientific Committee. Healthy adult SD
rats (~220-240 g) were anaesthetized with 1%
sodium pentobarbital intraperitoneally at a dose of
50 mg/kg. 
Bacteria
ATCC27853 is a standard line of PA obtained
from ATCC. Pseudomonas aeruginosa cultured in
broth for 18 h were diluted to 2 McFarland with
normal saline (6 × 108 CFU/ml, 1 McFarland = 3 × 108
CFU/ml).
Drug for treatment
Ambroxol hydrochloride injection (MucosolvanR)
(Boehringer Ingelheim Co. Ltd, China), 7.5 mg/ml.
Normal saline was used as the control of Ambroxol.
Methods
Animal experiment procedure
One hundred and twenty rats were divided
randomly into four groups, 30 rats in each group :
PA/NS group, PA/AM group, NS/AM group, NS/NS
group. The rats in the PA/NS group and PA/AM
group were anaesthetized with sodium pen  -
tobarbital (50 mg/kg) administered intraperi  toneally.
This study had two stages which contained animal
infected PA and the treatment of infection. 
After the trachea was exposed by blunt dissection
and tracheal annulations, all of them were instilled
with 0.2 ml P . aeruginosa suspension intratra  cheally
followed by an injection of 0.5 ml of air 
(2 McFarland units of ATCC27853 suspension
obtained according to the former methods) to copy
the pneumonia of rat models. After 6 h, these rats
were administered normal saline (the volume of NS
was 0.6 ml, which was equal to the volume of used
Ambroxol) and Ambroxol (20 mg/kg) through the
vena caudalis. Both the NS/AM group and NS/NS
group were given NS (0.2 ml) intratracheally. 
Six h later, the rats in the NS/AM group received
Ambroxol (20 mg/kg) and in the NS/NS group
received normal saline 0.6 ml via a 28 G catheter
respectively. Four groups were allowed to recover
and ad liter. 
Samples procedure
After 6 h, samples were obtained according to
the research aims. Most of them were referred as
follows.
1) Wet-to-dry lung weight measurements 
After the rats had been sacrificed, an incision
was made in the abdominal wall and the chest was
then opened. In each group (five animals), a piece
of lung tissue (about 2 g) from the back side of the
left lower lobe was cut and the wet weight was
406 Arch Med Sci 3, June / 2011
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determined in an automatic electric balance
(AP250D; Ohaus, Florham, NJ). All pieces of lung
tissue were then stored at 70°C for 72 h and
weighed again to obtain their dry weight for
calculating the wet-to-dry weight ratio (W/D).
In another four animals in each group both lungs
were fixed by vascular perfusion for histological
analysis. The pulmonary vessels were lavaged with
normal saline via right ventricular. The rat lungs
were fixed at the pressure of 20 cm H2O by
intratracheal injection of a solution containing 2%
glutaraldehyde and 1% paraformaldehyde in a 0.1 M
phosphate buffer solution. The lungs were then
prepared for sectioning using standard techniques.
Sections were stained with haematoxylin-eosin.
Polymorphonuclear cells (PMN) were counted on
each slide by a pathologist not knowing the
experiment project and repeated three times.
2) BALF
The volume of normal saline each animal needed
was counted according to the dose of 40 ml/kg.
Each rat needed 8.8-10.6 ml and was lavaged
according to the ratio of 4 : 3 : 3 three times. More
than 85% of the instilled liquid was collected from
each rat, and collected BALF was pooled and its
total volume was recorded. Total 0.1 ml BALF was
serially diluted and spread on blood agar plates for
calculation of viable colony-forming units (CFU) of
PA. After culture for 24 h at 37°C, all CFU were
counted. All other BALF was immediately centri  -
fuged for 3000 rpm lasting for 10 min to remove
the cell debris, the supernatant was stored at –20°C
for biochemical analysis. Samples for EM processed:
all procedures for samples are described in the
supplementary materials.
3) Chemical analysis of bronchoalveolar lavage fluid
and total protein
All analysis methods are presented in Appen  -
dixes 1 and 2.
Statistical analysis
Statistics were conducted using SPSS software
(SPSS, Chicago, IL) and the results are presented as
means ± SD. One-way analysis of variance (ANOVA)
procedures and post hoc analysis (LSD, significance
level set at p  < 0.05) were used for multiple
comparisons.
Results
The appearance of rats inoculated with PA
intratracheally and the weight ratio of wet/dry
of the rat lungs of each group 
After being inoculated with PA intratracheally
from one to 3 h, all rats in both the PA/NS group
and PA/AM group showed trembling, cyanosis, and
some blood-tinged foams out of mouths and noses.
All these rats breathed faster than before. Even one
or two rats twitched with their hair being wet.
Six h after being injected with Ambroxol, the rats
in the PA/NS group acted just like before, but
animals in the PA/AM group calmed down gradually.
All animals administered NS and Ambroxol
respectively in the first stage, which were referred
to NS/AM and NS/NS groups, did not show
uncomfortable appearance. 
To assay the water in the lungs of each group,
the wet/dry weight ratio (W/D) was calculated. It
was found that lung W/D increased significantly in
the PA/NS group, which was 8.58 ±0.39. This ratio
(7.47 ±0.22) in the PA/AM group was lower than
that in the PA/NS group (p < 0.05), but both of them
were significantly higher than that in both NS/AM
and NS/NS groups. There was no statistical
difference between NS/AM and NS/NS groups
(Figure 1).
Pathological appearance 
Macropathologically, the lungs weighed and
enlarged in all of the PA-challenged rats (PA/NS,
PA/AM group) much more than in NSor AM-
challenged ones (NS/AM, NS/NS groups). The
surfaces of the lungs from the PA-challenged rats
were roughened with some purulent spots or
pustules whose diameters were about 1-3 mm. The
lungs of the PA/NS group were cut into several
pieces; pink fluid was squeezed. The pulmonary
pathological changes showed a decreasing trend
of severity from the PA/NS to PA/AM group, while
the lungs from the rats of the NS/AM and NS/NS
group showed no changes. 
Pulmonary pathological study revealed striking
contrasts between the PA/NS group and the PA/AM
group. In the lung of rats from the PA/NS group, there
was bronchial mucosal epithelial cell exfoliation,
hyperaemia and oedema seen in the bronchial
submucosal layer with inflammatory cell infiltration,
most of which were neutrophils, a few lymphocytes
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Figure 1. Wet/dry ratio of the lung of each group:
wet/dry ratio of lung in PA/NS group was higher than
that in PA/AM group (p < 0.05); both were higher
than that in NS/AM and NS/NS group (p < 0.01),
#NS/AM and NS/NS group (p < 0.05) and PA /AM
group (p < 0.05), *any other group (p < 0.05)
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and macrophages. The alveolar walls were thickened
with telangiectasia and congestive capillaries. A large
amount of neutrophils and erythrocytes filled in the
alveoli in areas that developed pustules. Alveolar
septa ruptured in some portions of the lung due to
compensatory alveolar ectasia. Compared with the
PA/NS group, alveolar telangiectasia and congestive
capillaries in the PA/AM group attenuated, where
a scanty oedema fluid and lymphocytes were
scattered in the alveolar cavities. Although some
neutrophils and macrophages were found, they were
far fewer than those in the PA/NS group. There were
few inflammatory cells infiltrated in the lungs from
both the NS/NS group and AM/NS group, with
regular alveolar cavities. 
The inflammation of the lungs in each group was
consistent with the semi-quantitative results. The
neutrophils in high power were seen as a sign of
inflammatory reaction. The inflammatory reaction
in the PA/NS group was slightly more prominent
than that in the PA/AM group, but the latter was
considerably less than that in the NS/NS and
AM/NS group. The PMN number per high field in
the PA/NS group was 111.4 ±14.8, in the PA/AM
group 38.8 ±3.1, in the NS/AM group 6.0 ±4.4, and
in the NS/NS group 4.4 ±2.6. There was a significant
difference between the PA/NS group and all the
other groups (p < 0.05, Figure 2). The other corres  -
ponding groups had no significant difference.
Analysis of the pulmonary surfactant in BALF
of each group
Total protein in BALF was assayed from each
group and it was found that there was higher
concentration in the PA/NS group (87.0 ±8.9 mg/kg).
Ambroxol reduced TP in BALF in the PA/AM group,
in which it was 81.4 ±7.8 mg/kg, TP in NS/AM group
was 39.4 ±8.6 mg/kg, and in the NS/NS group was
36.6 ±6.1 mg/kg (Figure 3, p < 0.05, among any two
groups but not for NS/AM group).
The level of DPPC/TPL and DPPC/TP in the PA/NS
group was 38.6 ±11.0% and 19.1 ±6.9 μg/mg
respectively, which was lower than that in the
NS/NS group (49.6 ±5.4% and 59.8 ±14.7 μg/mg
respectively) (p < 0.05). However, TP in BALF in the
PA/NS group was higher than that in the NS/NS
group with no change of concentration of TPL
appearing in the PA/NS group. And there was no
significant difference of TPL between any two groups
(4.6 ±1.7 mg/kg for PA/NS group, 4.7 ±0.5 mg/kg for
PA/AM group, 4.1 ±1.5 mg/kg for NS/AM group and
4.4 ±1.1 mg/kg for NS/NS group respectively, p > 0.05
for all) (Figure 4).
The level of DPPC/TPL and DPPC/TP in the PA/AM
group elevated significantly compared to the PA/NS
group (65.7 ±7.8% and 38.6 ±11.0% respectively, 
p < 0.05). The concentration of DPPC/TP in BALF in
the PA/AM group elevated more than that in the
PA/NS group (38.6 ±10.2 μg/mg and 19.1 ±6.9 μg/mg
respectively, p < 0.05), but there was no change in
the concentration of TP and TPL (Figure 4). 
And also, it was found that DPPC/TPL concen  -
tration in the NS/AM group was higher than that
in the NS/NS group (68.3 ±8.4% and 38.6 ±11.0%
respectively, p < 0.05), with the level of DPPC/TP in
the NS/AM group being higher than that in the
NS/NS group, which may indicate that Ambroxol
could increase the biosynthesis of PS in the normal
rat lung (Figure 4).
Colony of bacteria in BALF of each group
There were no bacteria growing in media from
BALF of both NS/AM and NS/NS groups. And there
were many bacteria growing in media from BALF of
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Figure 2. Semi-quantitative analysis of PMNs per high
power field under the light microscope. After
pathological slides were prepared, analysis of PMN
was performed by a pathologist not knowing the
experiment project. PMN numbers per high power
field in PA/NS group were 111.4 ±14.8, in PA/AM group
38.8 ±3.1, in NS/AM group 6.0 ±4.4, and in NS/NS
group 4.4 ±2.6. There was a significant difference
between PA/NS group and all other groups *vs.
NS/NS group (p < 0.05), #vs. PA/AM group (p < 0.05)
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Figure 3. Total protein (TP) in BALF from lungs in each
group. TP in PA/NS group was higher than that in
NS/NS group (87.0 ±8.9 mg/kg and 36.6 ±6.1 mg/kg
respectively, p < 0.05), both were higher than that
in NS/AM and NS/NS group (p < 0.01), *vs. NS/NS
group (p < 0.05)
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both PA/NS and PA/AM groups, which were
identified as PA, whose biological features were just
like the bacteria inoculated intratracheally. There
were 10.35 ±2.10 (104 CFU/ml) and 8.02 ±3.2 
(104 CFU/ml) respectively in PA/NS and PA/AM
groups, but there was no statistical difference
between the two groups (p > 0.05) (Figures 5 A-C).
Performance of lungs under electron
microscopy
The normal ultramicrostructure of the lamellar
body in alveolar type II cells (AT2) and tubular myelin
(TM) for exocytosis being intruded into the alveolar
cavity could be found in both NS/NS and NS/AM
groups (Figure 6 E). The PS layer on the surface of
alveoli was homogeneous in both groups (Figure 6 F).
But in the PA/NS group, vacuolation occurred in the
lamellar body of AT2. The lattice and other types of
tubular myelin exfoliated into the alveolar cavity
(Figures 6 A, B). The PS layer was rough and was
broken in some areas. In the PA/AM group, the degree
of vacuolation of the lamellar body had more
tendency to recovery than those in the PA/NS group
and the PS layer was more perfectly distributed than
the PA/NS group (Figures 6 C, D).
Discussion
Here, by injecting PA ATCC27853 intratracheally,
rat pneumonia models were produced. After being
inoculated for 3 h, all rats challenged with PA
showed trembling, dyspnoea and hair-wet. The
pathological lungs weighed and enlarged in all of
the PA-challenged rats. Lung surfaces were rough
with some purulent spots or pustules. A pink water-
like fluid flowed from its cut cross-sectional surface
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Figure 4. Analysis of contents of BALF in lungs from
each group. Level of DPPC/TPL and DPPC/TP in
PA/AM group elevated significantly compared to
PA/NS group (65.7 ±7.8% and 38.6 ±11.0%
respectively, p < 0.05). Concentration of DPPC/TP in
BALF in PA/AM group elevated more than that in
PA/NS group (38.6 ±10.2 μg/mg and 19.1 ±6.9 μg/mg
respectively, p < 0.05). DPPC/TPL concentration in
NS/AM group was higher than that in NS/NS group
(68.3 ±8.4% and 38.6 ±11.0% respectively, p < 0.05),
with the level of DPPC/TP in NS/AM group being
higher than that in NS/NS group
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Figure 5. Lung histology. Sections of lungs were
prepared 6 h after being treated with NS and AM 
(A – PA/NS group, B – PA/AM group, C – NS/NS
group. Original magnifications: ×200).These sections
are representative of 5 to 10 different animals per
group410 Arch Med Sci 3, June / 2011
when squeezed. And also the lungs from the rats
challenged with PA showed higher W/D ratio than
that with NS and Ambroxol. More than that, PA
were cultured from BALF obtained from rats
challenged with PA, and their biological features
were identical to the inoculated ones. Under light
microscopy, inflammatory cells infiltrated the lungs
and most of them were neutrophils. All this
indicated that the pneumonia models succeeded.
To assay the BALF content, it was found that
TP in BALF from rats in the PA/NS group increased,
while DPPC/TPL, DPPC/TP decreased, which may
indicate that DPPC in PS was relatively lowered.
This work presented results just like those
obtained by Wanderzwan et al. [23]; they found
that the content of TPL, DPPC and large surfactant
aggregates (LSA) decreased. Together these assays
of the level of DPPC/TPL, DPPC/TP in BALF in
Figure 6. Electron microscopy. Sections of lungs were prepared 6 h after being treated with NS and AM and the
procedure was according to the supplementary materials online. Normal ultramicrostructure of lamellar body in
alveolar type II cells (AT2) and tubular myelin (TM) for exocytosis being intruded into alveolar cavity all could be found
in both NS/NS and NS/AM group (E). The PS layer on the surface of alveoli was uniform in these two groups (F). But
in PA/NS group, vacuolation occurred in lamellar body of AT2. Lattice and other types of tubular myelin exfoliated
into the alveolar cavity (A, B). PS layer was rough and was broken in some areas. In PA/AM group, degree of
vacuolation of lamellar bodies had more tendency to recovery than those in PA/NS group and PS layer was more
perfectly distributed than PA/NS group (C, D)
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severe pneumonia could suggest the prognosis of
pneumonia. 
Now it is suggested that phospholipase
secreted by bacteria may play some role to
decrease PS in bacterial pneumonia. Lema et al.
[24] found the calf lung surfactant extract
hydrolysis was catalyzed by extracts (mostly
phospholipase C) of the PA, particularly the non-
mucoid types, which severely affected surfactant
function. And they concluded that this mechanism
might be the most important injury factor. Here
in our study the lung in the PA/NS group under
electron microscopy presented that PS liner
ruptured and twisted, and even dropped into the
alveolar cavities, which indicated that some
conconts of PA injured the PS liner. If being given
Ambroxol, the extent of injury lessened.
It is well known that the PS is synthesized and
secreted by AT2, most of which consists of phospho  -
lipids (PL) and up to 80% to 85%, mainly dipalmi  -
toylated phosphatidylcholine (DPPC) and phosphati  -
dyl  glyceride (PG), and acts to maintain alveolar
stability. And also, PS, especially PL, can modulate
the inflammatory reaction of normal and abnormal
lungs, and even has bacteria-inhibiting effects [12,
25]. Among all contents of PS, SP-D plays a more
important role than any other. There were some
results about human pneumonia that showed
decreased SP-A in patients with bacterial pneumonia
[26].
From the results, it could be found that there
was a large amount of infiltration in the alveolar
cavity, increased W/D ratio, and also TP rise, and
lower DPPC/TPL and DPPC/TP . All these combined
together may indicate the deficiency or impairment
of the PS layer, and this gave evidence of
exogenous PS replacement. Some researchers [27]
found that a large amount (~300-500 mg/kg b.w.)
by intrabronscopic administration in septic shock
patients caused far-reaching restoration of
biochemical surfactant properties and significant
improvement. With this method, gas-exchange
ability rose significantly. And Protsiuk [28] used
exogenous PS associated with antibiotics to treat
pneumonia in children and found that the effect of
two methods was much better than that of only
antibiotics. Now, Ambroxol has been used for many
years all over the world to manage respiratory tract
disorders. This compound was originally developed
as a mucolytic agent [29], but it was soon disco  -
vered that it influences the secretory apparatus of
the bronchial epithelium and pulmonary alveoli.
There is now ample evidence that Ambroxol is
a very potent inducer of surfactant synthesis in
young and adult organisms and in alveolar type II
cells from different animal species [30]. The
mechanism has not yet been understood com  -
pletely. Von Vichert et al. [31] reported that Ambro  -
xol in healthy rabbits increases the phospholipid
content of the lung.
This study also proved by EM that Ambroxol
could promote the function of PS. In rats from
PA/NS group, it was found that vacuolation occurred
in the lamellar body in AT2. The lattice and other
types of tubular myelin exfoliated into the alveolar
cavity. The PS layer was rough and was broken in
some areas. In the PA/AM group, the degree of
vacuolation of the lamellar body had more tendency
to recovery than those in the PA/NS group and the
PS layer was more perfectly distributed in the AT2
than that in the PA/NS group, and few lamellar
bodies exfoliated. This result indicated that after
AT2 were stimulated, the synthesis and secretion
of PS also increased.
Another study indicated that Ambroxol can help
to increase the local concentration of antibiotics
and reduce the morbidity of infectious diseases [32,
33]. In our work, though there was no statistical
difference regarding the amount of bacteria’s CFU
between the PA/NS group and PA/AM group 
(p > 0.05), the inflammatory infiltration of lungs in
the PA/AM group was less than that in the PA/NS
group. Yang et al. [34] suggested that Ambroxol
protected mice challenged with influenza virus from
lethal effects and improved the mice survival rate
partly through inhibiting the releasing of cytokines
such as TNF-α, IFN-γ and IL-12, and promoting the
secretion of the release of suppressors of influenza
virus multiplication, such as pulmonary surfactant
(mostly SP-A, rising 1.5-1.7 fold), immunoglobulin
(Ig)-A and IgG, etc. Therefore it may be that
Ambroxol could stimulate the synthesis and
secretion of exogenous PS in lungs of infected rats
and exert a protective effect. Further, analysis of
BALF of non-infected rats suggested that this
stimulation was not limited to infected rats, which
meant in normal rat lungs Ambroxol acted in the
same role. Now, exogenous PS is very expensive
and there is no standard about this drug. But all
packages of Ambroxol are relatively economical and
the usage is relatively simple, so it perhaps acts on
the responsibility and aids in severe or resistant
lung infection. The definite mechanism of this drug
might need to be investigated.
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Appendix 1
Immediately after the last cardiac beat the
tracheal perfusion at 40 cm H2O pressure with 3 ml
25% glutaraldehyde in 0.1% phosphate buffer (pH
7.0) preceded the clamping of the trachea. The
heart-lung block was sectioned and immersed in
3% glutaraldehyde for 1 h. Ten samples (5 sub  -
pleural and 5 central) measuring about 1 × 1 mm for
TEM were taken from each lobe of the right lung
(cranial, middle, caudal, postcaval) and from the left
lung lobe. These samples were prefixed in 3%
glutaraldehyde in 0.1% phosphate buffer (pH 7.0)
for 3 h and washed 3 times with the same
phosphate buffer. The samples were postfixed in
a phosphate buffer 1% OsO4 at 6°C for 3 h,
dehydrated in a graded ethanol series, infiltrated
with propylene oxide and embedded in Ladd’s epon
LX-112. From both edges of all blocks, 20 semiserial
(interval 20 μm) semifine sections (0.5 μm) were
prepared and stained with toluidine blue for light
microscopic (LM) analysis. According to the LM
findings (presence and number of diatoms in
alveolar space and/or close to the alveolar wall,
positive findings, etc.) a strike selection of the blocks
(exclusion rate = 98%) was performed and 5 were
analysed. From the selected samples, serial and
semiserial (interval 0-40 μm) semifine sections were
prepared and a step-by-step decision was made
whether or not to prepare 5-10 ultrathin serial
sections. The ultrathin sections were stained on
grids using uranyl acetate and lead citrate. For the
ultrastructural study and micrography a HITACHI 
H-800 electron microscope was used.
Appendix 2
Aliquots of BALF were extracted with threefold
volumes of chloroform-methanol (2 : 1, vol/vol) to
isolate the phospholipids in the chloroform phase.
DSPC was separated from other phospholipids as
described by Mason et al. [20]. Briefly, samples from
the chloroform phase were dried under nitrogen
gas, oxidized with small volume of osmium
tetroxide in carbon tetrachloride for 15 min, and
dried again under nitrogen, dissolved in chloroform-
methanol (20 : 1, vol/vol), and passed through
a neutral aluminium column. The DSPC fraction was
collected by adding to the column a mobile phase
of chloroform-methanol-7M ammonium hydroxide
(70 : 30 : 2, vol/vol/vol). Amounts of DSPC and TPL
were determined according to the methods
described by Bartlett [21] and corrected by the total
volume of BALF and body weight. Values for TPL are
presented as milligrams per kilogram, DSPC as
a percentage of the TPL (DSPC/TPL). Total proteins
(TP) in BALF were measured according to the
method of Lowry et al. [22], using bovine serum
albumin as the standard, and corrected by total
volume of BALF and body weight; these values are
presented as milligrams per kilogram. The DSPC
and TP ratio was expressed as micrograms per
milligram.